In past four months, the stock price of ION Exchange has appreciated by 53 per cent after it turned ex-date for sub-division / stock split in the ratio of 10:1 i.e. 1 equity share of face value of Rs 10 each sub-divided into 10 equity shares of face value of Re 1 each.
Meanwhile, thus far in the calendar year 2023, the stock price of the company has more-than-doubled or zoomed 127 per cent, as compared to 8.7 per cent rise in the S&P BSE Sensex.
ION Exchange offers a wide range of solutions across the water cycle from pre- treatment to process water treatment, waste water treatment, recycle, zero liquid discharge, sewage treatment, packaged drinking water, sea water desalination etc.
The group is also engaged in manufacturing resins, speciality chemicals for water and waste water treatment as well as non-water applications. The group’s water and environment management solutions extend beyond the industrial sector to homes, hotels, spas, educational institutions, hospitals, laboratories, realty sector, defense establishments and rural communities, providing safe drinking water and a clean environment.
CRISIL Ratings believes ION Exchange will continue to benefit from its established market position, healthy order pipeline in the engineering division, strong profitability in the chemicals division and an improved business risk profile.
ION Exchange to sustain the consolidated topline growth in fiscal 2024 in line with as witnessed in the previous fiscal, on the back of strong order book for Engineering segment of ~Rs 3,351 crore as on June 30, 2023 duly supported by new acquisition and strong demand from end-users spread across the industries, according to the rating agency.
Consequently, ION Exchange is likely to generate net cash accruals of above Rs 250 crore in the same period. Operating margin is expected to be range bound at 13-14 per cent in fiscal 2024, primarily driven by the healthy operating profitability of above 20%in the chemicals division. In fiscal 2023, consolidated revenue grew by ~26 per cent with sustained operating margin of ~13 per cent, leading to increase in the net cash accruals to ~Rs 224 crore.
The company’s recent acquisition of a Portugal based company MAPRIL (acquisition completed in Q1FY2024 at a total consideration of ~Rs 24 crore, funded from internal accruals), will provide better access to the European market and increase the product offerings in chemical division, the rating agency said in rationale.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)